missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human CD163L1 (aa 1393-1452) Control Fragment Recombinant Protein
Click to view available options
Quantité:
100 μl
Conditionnement:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (33%), Rat (33%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-53362 (PA5-53362. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
This gene encodes a member of the scavenger receptor cysteine-rich (SRCR) superfamily. Members of this family are secreted or membrane-anchored proteins mainly found in cells associated with the immune system. The SRCR family is defined by a 100-110 amino acid SRCR domain, which may mediate protein-protein interaction and ligand binding. The encoded protein contains twelve SRCR domains, a transmembrane region and a cytoplasmic domain. Alternatively spliced transcript variants encoding different isoforms have been described but their full-length nature has not been determined.
Spécification
Spécification
| Numéro d’adhésion | Q9NR16 |
| Concentration | ≥5.0 mg/mL |
| À utiliser avec (application) | Blocking Assay, Control |
| Formule | 1 M urea, PBS with no preservative; pH 7.4 |
| Identification génétique (Entrez) | 283316 |
| Nom | Human CD163L1 (aa 1393-1452) Control Fragment |
| Quantité | 100 μl |
| État réglementaire | RUO |
| Alias de gène | CD163 antigen B; CD163 antigen-like 1; CD163 molecule like 1; CD163 molecule-like 1; CD163B; CD163L1; M160; SCARI2; scavenger receptor cysteine-rich type 1 protein M160; UNQ6434/PRO23202 |
| Nom usuel | CD163L1 |
| Afficher plus |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu